world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Fig. 5.120 Age-specific incidence and mortality of pancreatic <strong>cancer</strong> in men and women in North<br />
America. The small differences between incidence and mortality reflect the very poor prognosis of this<br />
disease. Men are somewhat more frequently affected than women.<br />
ease. These include unexplained weight<br />
loss, nausea, diarrhoea, weakness, jaundice<br />
(caused by compression of the intrapancreatic<br />
common bile duct) and upper<br />
abdominal and back pain. Mature onset<br />
diabetes in the absence of a family history<br />
may also indicate the possibility of pancreatic<br />
<strong>cancer</strong>. Insulin antagonism by<br />
tumour-produced factors (islet amyloid<br />
peptide, glucagon and somatostatin) is<br />
believed to be the cause [4]. Whilst 85% of<br />
patients have systemic disease or locally<br />
unresectable tumours on clinical evaluation,<br />
some 25% have symptoms compatible<br />
with upper abdominal disease up to six<br />
months prior to diagnosis and 15% of<br />
patients seek medical attention more than<br />
six months prior to diagnosis [5].<br />
Ultrasonography is the initial diagnostic<br />
imaging system currently employed,<br />
although visualization of the body and tail<br />
of the pancreas is often unsatisfactory due<br />
to the presence of intestinal gas. Computed<br />
tomography (CT) scanning allows<br />
clearer imaging of the tail and body and<br />
can detect lesions of >1 cm with accuracy,<br />
as well as secondary signs of pancreatic<br />
<strong>cancer</strong>, such as dilation of common bile<br />
and main pancreatic ducts, invasion of surrounding<br />
structures, liver secondaries,<br />
lymphadenopathy and ascites (Fig. 5.122).<br />
Cytological or histological confirmation is<br />
obtained from samples taken during endoscopic<br />
retrograde cholangiopancreatography,<br />
or by fine needle aspiration and core<br />
biopsy under radiological guidance. However,<br />
it is often difficult to obtain histological<br />
proof for small lesions, which have the<br />
best potential for curative surgery.<br />
Patients who are candidates for surgery<br />
undergo ultrasound and laparoscopy,<br />
which identify those with small peritoneal<br />
and liver nodules below the resolution of<br />
current imaging.<br />
Pathology and genetics<br />
The first stage of neoplasia (Fig. 5.124),<br />
flat hyperplasia, entails the columnarization<br />
of the ductal epithelium. It is estimated<br />
that as many as half the normal elderly<br />
population may exhibit flat hyperplasia [6].<br />
This may advance to papillary hyperplasia,<br />
the presence of a crowded mucosa with a<br />
folded structure, which may possess varying<br />
degrees of cellular and nuclear abnormalities.<br />
True carcinoma is characterized<br />
by invasion of the ductal wall and a<br />
desmoplastic response, i.e. acollagenous,<br />
inflammatory reaction, such that the<br />
tumour may comprise less than 25% <strong>cancer</strong><br />
cells. The major histological types<br />
include benign microcystic serous adeno-<br />
Fig. 5.121 Cigarette smoking is one of the main<br />
risk factors for pancreatic <strong>cancer</strong>.<br />
L<br />
G<br />
K<br />
S<br />
Fig. 5.122 A CT image of a mucinous cystic neoplasm<br />
in the pancreas. The thick wall shows focal<br />
calcification. T = tumour, K = kidney, L = liver, S =<br />
spinal cord, G = gallbladder.<br />
T<br />
Fig. 5.123 Surgical specimen of a pancreatic ductal<br />
adenocarcinoma (T) in the head of the pancreas.<br />
SI = small intestine.<br />
ma, tumours of uncertain biological<br />
behaviour, including mucinous cystic<br />
tumour and solid cystic tumour, as well as<br />
malignant forms, such as adenocarcinoma,<br />
microcystic serous adenocarcinoma<br />
and mucinous cystadenocarcinoma.<br />
T<br />
K<br />
SI<br />
Pancreatic <strong>cancer</strong><br />
249